FAILURE RATES OF LEADS, PULSE GENERATORS, AND PROGRAMMERS HAVE NOT DIMINISHED OVER THE LAST 20 YEARS - FORMAL MONITORING OF PERFORMANCE IS STILL NEEDED
Dt. Kawanishi et al., FAILURE RATES OF LEADS, PULSE GENERATORS, AND PROGRAMMERS HAVE NOT DIMINISHED OVER THE LAST 20 YEARS - FORMAL MONITORING OF PERFORMANCE IS STILL NEEDED, PACE, 19(11), 1996, pp. 1819-1823
Formal Monitoring of Performance is Still Needed. In order to detect t
rends in the number of device or component failures that have occurred
among permanent pacemaker systems since the 1970s, we reviewed the da
ta of the five largest pacemaker manufacturers from the Bilitch Regist
ry of permanent pacemaker pulse generators, the Stimarec failure regis
try, the general accounting office summaries of the United States Vete
rans Administration (VA) Registry of Pacemaker Leads, and the Implanta
ble Lead Registry, from the Cleveland Clinic Lead registry, and the re
calls and safety alerts issued by the United States Food and Drug Admi
nistration (FDA) over the last 20 years. The definition of failure fol
lowed the criterion, or criteria, developed within each registry and d
iffered significantly between the registries. The 20-year period betwe
en 1976 and 1995 was divided into 5-year quartiles (QT): QT1 = 1976-19
80; QT2 = 1981-1985; QT3 = 1986-1990; and QT4 = 1992-1995. For pulse g
enerators, the number of models with failures in each quartile in the
Bilitch Registry were: QT1 = 9; QT2 = 11; QT3 = 17; QT4 = 13. In Stima
rec, the number of units reported as having reached a dangerous condit
ion were: QT1 = 710; QT2 = 212; QT3 = 114; QT4 = 310. From the FDA rep
orts, the number of units included in recalls or safety alerts were: Q
T3 = 6,085; QT4 = 135,766. For permanent pacemaker leads, the numbers
of failed or dangerous leads recorded in Stimarec were: QT3 = 16; QT4
= 32. In the VA Registry, the number of models having a below average
survival was 2/92 (2.7%). In the Implantable Lead Registry,;the number
of models having a below average survival was 3/21 (14%). In the Clev
eland Clinic series, 6/13 (46%) of lead models were recognized to have
some failure involving the conductor, insulation, or connector. In th
e FDA reports, the number of leads involved in either recall or safety
alert were: QT3 = 20,354; QT4 = 332, 105. For programmers, the number
of units involved either in a recall or safety alert were: QT3 = 11,1
24; QT4 = 3,528. In all of these series, each of the five largest manu
facturers had some models or units involved in each time period. This
review of programs has revealed: 1. The incidence of failures, recalls
, or safety alerts did not decline over time; and 2. Despite changes i
n technology, formal monitoring of pacemaker systems is still warrante
d.